Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review.

IF 3.1 3区 医学 Q1 PRIMARY HEALTH CARE
Sarah Serhal, Ines Krass, Lynne Emmerton, Bonnie Bereznicki, Luke Bereznicki, Sinthia Bosnic-Anticevich, Bandana Saini, Laurent Billot, Carol Armour
{"title":"Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review.","authors":"Sarah Serhal,&nbsp;Ines Krass,&nbsp;Lynne Emmerton,&nbsp;Bonnie Bereznicki,&nbsp;Luke Bereznicki,&nbsp;Sinthia Bosnic-Anticevich,&nbsp;Bandana Saini,&nbsp;Laurent Billot,&nbsp;Carol Armour","doi":"10.1038/s41533-022-00315-6","DOIUrl":null,"url":null,"abstract":"<p><p>Uptake and outcomes of pharmacist-initiated general practitioner (GP) referrals for patients with poorly controlled asthma were investigated. Pharmacists referred at-risk patients for GP assessment. Patients were categorized as action takers (consulted their GP on pharmacist's advice) or action avoiders (did not action the referral). Patient clinical data were compared to explore predictors of uptake and association with health outcomes. In total, 58% of patients (n = 148) received a GP referral, of whom 78% (n = 115) were action takers, and 44% (n = 50) reported changes to their asthma therapy. Patient rurality and more frequent pre-trial GP visits were associated with action takers. Action takers were more likely to have an asthma action plan (P = 0.001) at month 12, and had significantly more GP visits during the trial period (P = 0.034). Patient uptake of pharmacist-initiated GP referrals was high and led to GP review and therapy changes in patients with poorly controlled asthma.</p>","PeriodicalId":19470,"journal":{"name":"NPJ Primary Care Respiratory Medicine","volume":" ","pages":"53"},"PeriodicalIF":3.1000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668973/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Primary Care Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41533-022-00315-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 1

Abstract

Uptake and outcomes of pharmacist-initiated general practitioner (GP) referrals for patients with poorly controlled asthma were investigated. Pharmacists referred at-risk patients for GP assessment. Patients were categorized as action takers (consulted their GP on pharmacist's advice) or action avoiders (did not action the referral). Patient clinical data were compared to explore predictors of uptake and association with health outcomes. In total, 58% of patients (n = 148) received a GP referral, of whom 78% (n = 115) were action takers, and 44% (n = 50) reported changes to their asthma therapy. Patient rurality and more frequent pre-trial GP visits were associated with action takers. Action takers were more likely to have an asthma action plan (P = 0.001) at month 12, and had significantly more GP visits during the trial period (P = 0.034). Patient uptake of pharmacist-initiated GP referrals was high and led to GP review and therapy changes in patients with poorly controlled asthma.

Abstract Image

患者摄取和结果后,药剂师发起转介到全科医生的哮喘审查。
对控制不佳的哮喘患者的药剂师发起的全科医生(GP)转诊的吸收和结果进行了调查。药剂师推荐高危患者进行全科医生评估。患者被分类为采取行动者(根据药剂师的建议咨询他们的全科医生)或行动回避者(不采取转诊行动)。对患者临床数据进行比较,以探索摄取的预测因素及其与健康结果的关联。总的来说,58%的患者(n = 148)接受了全科医生转诊,其中78% (n = 115)采取了行动,44% (n = 50)报告改变了他们的哮喘治疗。患者的乡村性和更频繁的试验前全科医生就诊与采取行动的人有关。在第12个月时,采取行动的患者更有可能制定哮喘行动计划(P = 0.001),并且在试验期间有更多的全科医生就诊(P = 0.034)。患者对药剂师发起的全科医生转诊的接受程度很高,导致控制不良哮喘患者的全科医生审查和治疗改变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine PRIMARY HEALTH CARE-RESPIRATORY SYSTEM
CiteScore
5.50
自引率
6.50%
发文量
49
审稿时长
10 weeks
期刊介绍: npj Primary Care Respiratory Medicine is an open access, online-only, multidisciplinary journal dedicated to publishing high-quality research in all areas of the primary care management of respiratory and respiratory-related allergic diseases. Papers published by the journal represent important advances of significance to specialists within the fields of primary care and respiratory medicine. We are particularly interested in receiving papers in relation to the following aspects of respiratory medicine, respiratory-related allergic diseases and tobacco control: epidemiology prevention clinical care service delivery and organisation of healthcare (including implementation science) global health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信